Decitabine, a DNMT inhibitor, and vorinostat, an HDAC inhibitor, upregulate the expression of multiple tumor suppressor genes, such as CDKN2A and TP53, thus inducing cellular senescence via these pathways in various cancer cells.865,1376. The gene discussed is DNMT1; the disease is cancer.